Skip to content

Clinical trials

Observational Inflammatory Bowel Diseases trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Phase: Observational Country / region: China Clear all

54 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20122
20141
20151
20175
20181
20193
20205
20217
20225
20238
20243
202510
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status18
Completed17
Recruiting14
Not yet recruiting2
Terminated1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Second Affiliated Hospital, Zhejiang University, School of Medicine8
Sixth Affiliated Hospital, Sun Yat-sen University6
Children's Hospital of Fudan University4
Nanfang Hospital, Southern Medical University4
Second Affiliated Hospital of Wenzhou Medical University4
Shandong University3
Xijing Hospital3
Changhai Hospital2
AbbVie1
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases54
Crohn Disease14
Colitis, Ulcerative13
Colorectal Neoplasms4
Irritable Bowel Syndrome3
Clostridium Infections2
Digestive System Diseases2
Adenoma1
Atherosclerosis1
Behcet Syndrome1

Trials

Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.